-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Downgrades Foghorn Therapeutics to Neutral

Benzinga·10/02/2026 09:24:04
Diffusion vocale
BTIG analyst Jeet Mukherjee downgrades Foghorn Therapeutics (NASDAQ:FHTX) from Buy to Neutral.